Biora Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ATHYRIUM CAPITAL MANAGEMENT, LP | 02/14/2023 | 42.36 M | $5.58 M | 41.89% | 22.19% |
ARMISTICE CAPITAL, LLC | 02/14/2023 | 8.37 M | $1.10 M | 100.00% | 4.38% |
VANGUARD GROUP INC | 02/10/2023 | 5.90 M | $777,073 | 0.04% | 3.09% |
GSA CAPITAL PARTNERS LLP | 02/13/2023 | 2.09 M | $275,000 | 157.22% | 1.09% |
MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 1.85 M | $244,000 | 99.33% | 0.97% |
BLACKROCK INC. | 02/13/2023 | 1.63 M | $214,257 | 0.00% | 0.85% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 1.10 M | $167,000 | -5.76% | 0.58% |
STATE STREET CORP | 05/15/2023 | 439,347 | $57,862 | 0.00% | 0.23% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2023 | 432,000 | $56,894 | 0.00% | 0.23% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 399,200 | $51,896 | -34.91% | 0.21% |
CITADEL ADVISORS LLC | 02/14/2023 | 269,800 | $35,533 | 29.28% | 0.14% |
NORTHERN TRUST CORP | 02/13/2023 | 217,150 | $28,599 | 0.00% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 213,337 | $28,096 | -55.23% | 0.11% |
CITADEL ADVISORS LLC | 02/14/2023 | 161,636 | $21,287 | 365.97% | 0.08% |
BARCLAYS PLC | 02/13/2023 | 144,927 | $19,000 | 0.00% | 0.08% |
CITADEL ADVISORS LLC | 02/14/2023 | 102,700 | $13,526 | -9.03% | 0.05% |
SABBY MANAGEMENT, LLC | 02/14/2023 | 98,993 | $13,037 | -65.58% | 0.05% |
TWO SIGMA SECURITIES, LLC | 02/14/2023 | 89,080 | $11,732 | 100.00% | 0.05% |
INDEPENDENT ADVISOR ALLIANCE | 02/13/2023 | 78,362 | $5,288 | 25.61% | 0.04% |
HRT FINANCIAL LP | 02/10/2023 | 73,599 | $9,000 | 301.24% | 0.04% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 61,000 | $8,000 | 476.12% | 0.03% |
BANK OF NEW YORK MELLON CORP | 02/14/2023 | 56,455 | $7,435 | 0.00% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 56,100 | $7,293 | -63.64% | 0.03% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 55,500 | $7,000 | 100.00% | 0.03% |
HAP TRADING, LLC | 02/14/2023 | 46,300 | $1,000 | -24.47% | 0.02% |
WELLS FARGO & COMPANY/MN | 02/13/2023 | 38,503 | $5,071 | -3.79% | 0.02% |
GROUP ONE TRADING, L.P. | 02/09/2023 | 35,877 | $4,725 | 100.00% | 0.02% |
BLUEFIN CAPITAL MANAGEMENT, LLC | 02/14/2023 | 33,820 | $4,454 | 0.30% | 0.02% |
SIMPLEX TRADING, LLC | 02/02/2023 | 32,830 | $4,000 | 100.00% | 0.02% |
LEONARD RICKEY INVESTMENT ADVISORS P.L.L.C. | 01/27/2023 | 32,632 | $4,298 | 22.53% | 0.02% |
LPL FINANCIAL LLC | 02/07/2023 | 22,979 | $3,026 | 100.18% | 0.01% |
VICTORY CAPITAL MANAGEMENT INC | 04/25/2023 | 18,850 | $2,483 | -0.04% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 02/10/2023 | 17,186 | $2,000 | 0.00% | 0.01% |
MORGAN STANLEY | 02/14/2023 | 15,281 | $2,013 | -79.91% | 0.01% |
CUTLER GROUP LLC / CA | 02/07/2023 | 10,831 | $1,000 | -18.75% | 0.01% |
JANE STREET GROUP, LLC | 02/15/2023 | 10,724 | $1,413 | -85.53% | 0.01% |
WEALTHTRUST AXIOM LLC | 01/31/2023 | 10,000 | $32,925 | 0.00% | 0.01% |
CUTLER GROUP LLC / CA | 02/07/2023 | 4,600 | $15,000 | -35.21% | 0.00% |
ADVISORNET FINANCIAL, INC | 01/13/2023 | 3,856 | $508 | 0.00% | 0.00% |
CNB BANK | 02/13/2023 | 975 | $128 | 100.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/15/2023 | 800 | $105 | 100.00% | 0.00% |
RIGGS ASSET MANAGMENT CO. INC. | 01/30/2023 | 550 | $72 | 100.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 02/14/2023 | 462 | $0 | 100.00% | 0.00% |
US BANCORP \DE\ | 02/13/2023 | 387 | $51 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/10/2023 | 366 | $48 | 100.00% | 0.00% |
ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/06/2023 | 180 | $0 | 0.00% | 0.00% |
MONEY CONCEPTS CAPITAL CORP | 02/14/2023 | 92 | $12 | 100.00% | 0.00% |
HORAN SECURITIES, INC. | 01/17/2023 | 20 | $3 | 100.00% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2023 | 18 | $0 | -87.05% | 0.00% |
FMR LLC | 02/13/2023 | 8 | $1 | 100.00% | 0.00% |
Biora Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Biora Therapeutics, Inc.. The most heavily invested institutionals were:
Surevest, LLC: 0
Urban Wealth Management, LLC: 890
34.43% of Biora Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 890 shares in the last 24 months. This purchase volume represents approximately $196 in transactions.